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Abstract The aim of this study was to identify determi-
nants of functional disability, patient’s quality of life (QoL)
and caregivers’ burden in Huntington’s disease (HD). Eighty
HD patients participated in the study. Motor and behavioral
disturbances as well as cognitive impairment were assessed
using motor, behavioral and cognitive parts of the Unified
Huntington Disease Rating Scale (UHDRS); Hamilton
Depression Rating Scale was used to assess depression.
Disability, health-related QoL and the impact of the disease
on the caregivers were assessed using the following methods:
UHDRS Functional Assessment Score, SF-36 Scale and
Caregiver Burden Inventory. Multiple regression analysis
showed that motor disturbances, cognitive impairment,
apathy and disease duration were the independent predictors
of disability. Depression and cognitive disturbances were the
determinants of patient’s QoL, while motor disturbances and
depression were the predictors of the caregiver burden.
Patient’s disability and QoL as well as caregivers’ burden
should be taken into consideration while planning treatment
strategy and the results of the present study show that the
predictors of those treatment targets are different.
Keywords Disability  Quality of life  Caregiver burden 
Huntington’s disease
Introduction
Huntington’s disease (HD) is an inherited progressive
neurodegenerative disorder, which affects patients’ cogni-
tive, emotional and motor functions and causes severe
disability. Apart from involuntary movements (choreic and
dystonic) and bradykinesia, HD is associated with cogni-
tive impairment leading to dementia and a wide range of
neuropsychiatric problems, e.g., apathy, depression, anxi-
ety and other behavioral disturbances. Physicians usually
focus on motor signs when planning treatment, while the
behavioral or cognitive disturbances may influence patient
and caregiver’s lives to a greater extent than motor
symptoms (Hamilton et al. 2003).
Most of the HD patients are unaware of their involuntary
movements, which are apparent to the physician (Snowden
et al. 1998; Sitek et al. 2011). The severity of disease may
be therefore perceived differently by physicians and
patients. The physician assesses the severity of symptoms
objectively, while the patient focuses on the subjective
perceptions of limitations caused by the disease. Hence, the
patient’s point of view may be better expressed by the
quality of life (QoL) than disability measures. In addition,
the severity of disease from the caregiver’s perspective is
affected mainly by the amount of physical and emotional
effort invested in the patient’s care (Roscoe et al. 2009).
Previous studies did not provide a comprehensive
analysis of predictors of disability (Hamilton et al. 2003;
Marder et al. 2000) or QoL (Ready et al. 2008; Ho et al.
2009), but focused rather on a single symptom or a group
of symptoms of HD and their significance. The aim of the
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present study was to identify the predictors of patients’
disability, QoL and caregivers’ burden in Huntington
disease.
Patients
Eighty HD patient-caregiver dyads recruited from the
Movement Disorders Clinic of the Department of Neurol-
ogy, Jagiellonian University Medical College in Krakow
(41 subjects) and from the Movement Disorders Outpatient
Clinic from St. Adalbert Hospital in Gdansk (39 subjects)
volunteered for the study. The recruitment was performed
between May 2007 and October 2008. The diagnosis was
confirmed by DNA analysis for CAG expansion in htt
gene.
Participants were selected from a cohort of patients who
participate in the European Huntington Disease Network
(EHDN) Registry study (Orth et al. 2011). Registry is a
multicenter research observational project, for individuals
affected by HD. Inclusion criterion was the adult onset HD
in a borderline to advanced stage. All participants provided
informed consent for participation in the Registry study.
The study was approved by the Central Ethics
Commission.
Methods
In order to assess the implications of the disease from three
different points of view, the following aspects were ana-
lyzed: functional disability, QoL and caregiver burden. In
order to evaluate disability, the Functional Assessment
Score (FAS), which is a part of the Unified Huntington
Disease Rating Scale (UHDRS), was used (Huntington
Study Group 1996). SF-36 Scale was used to assess health-
related QoL and Caregiver Burden Inventory (CBI) Scale
(Novak and Guest 1989) was used to estimate the impact of
the disease on the caregivers.
The severity of HD symptoms was also assessed in each
patient. For motor disturbances assessment, UHDRS Motor
Examination was used. The scale consists of several items
including the assessment of chorea, dystonia, bradykinesia,
gait and oculomotor impairment. Cognitive dysfunction
was assessed with use of the cognitive part of the UHDRS
(consisting of Stroop test, verbal fluency trials and Symbol
Digit Modalities Test). Depression was evaluated using
Hamilton Depression Rating Scale (HAM-D). The severity
and frequency of each behavioral symptom were evaluated
using UHDRS Behavioral Assessment. Each behavioral
symptom was scored 0 to 4, separately for severity and
frequency. Higher scores on the UHDRS motor and
behavioral scales and CBI are associated with greater
impairment. Higher scores on the UHDRS Cognitive and
FAS Scales were related to better cognitive function and
less significant disability. Higher scores on SF-36 ques-
tionnaire were associated with better QoL.
Statistical analysis
Simple linear regression analysis was used to assess the
contribution of the explanatory variables to FAS, SF-36
and CBI. Separate analyses were performed for each out-
come measure. The following variables corresponding to
specific HD symptoms were included in the analysis:
UHDRS Motor, UHDRS Cognitive, HAM-D, UHDRS
Behavioral Assessment subscores separately for apathy,
psychotic symptoms (including joint assessment of delu-
sions and hallucinations), irritability, aggression and anxi-
ety. Other factors comprised age, gender, age at disease
onset, disease duration, CAG repeat number and duration
of education. Bonferroni-adjusted alpha level of 0.003 was
used for multiple comparisons.
Significant predictors obtained from the simple regres-
sion analyses were included in the forward stepwise
regression models that were developed separately for each
dependent variable.
The coefficient of determination (R2) in the simple
analysis as well as beta (b) coefficient in the multiple
analyses were interpreted as the measures of contribution
of each variable to disability, QoL or caregiver burden. The
level of significance for multiple regression analysis was
set to 0.05.
Results
Demographic characteristics as well as motor, cognitive
and behavioral UHDRS scores of patients are presented in
Table 1. Participants from two study sites did not differ
significantly in terms of demographic and illness-related
features; therefore, further analysis was performed on the
pooled data. Six patients were unable to answer questions
of the SF-36 questionnaire.
Functional disability
Simple regression analysis showed that UHDRS Motor,
UHDRS Cognitive, HAM-D, and UHDRS Behavioral total
as well as Apathy subscore and disease duration were
correlated with FAS. Irritability, Aggression, Anxiety and
Psychotic symptoms subscores were not significantly
related to disability (see Tables 2, 3). In the multiple
regression analysis, UHDRS Motor, UHDRS Cognitive
and UHDRS Apathy subscore and disease duration were
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the independent predictors of disability (adjusted
R2 = 0.74 for the model).
Quality of life
UHDRS Motor, UHDRS Cognitive, HAM-D, FAS,
UHDRS Behavioral total score and Apathy subscore were
related to QoL in the simple regression analysis (see
Table 2). In multiple regression, the independent factors of
QoL were the measures of depression and cognitive func-
tion (adjusted R2 = 0.55 for the model).
Caregiver burden
In the simple regression analysis, UHDRS Motor, HAM-D
and FAS were identified to influence CBI score (see
Table 2). UHDRS Motor and HAM-D were the only sig-
nificant independent factors in the multiple analysis.
However, the coefficient of determination for the model
was rather low (adjusted R2 = 0.39).
Discussion
The results of the present study show that different
symptoms of HD contribute to functional disability, QoL
and caregiver burden. Motor symptoms, cognitive impair-
ment, apathy and disease duration seem to influence sig-
nificantly the functional disability. Depression and
cognitive impairment determine the patient’s quality of
life, while caregiver burden is mostly influenced by motor
symptoms and depression. Due to the co-occurrence of
several symptoms in a single patient, the exact contribution
of a single symptom on the outcome measures is usually
difficult to estimate.
The first study on the discrepancy between patients’ and
their family members’ perception of the most disturbing
features of HD was published by Stern and Eldridge
(1975). According to those authors, physical disturbances
were the most disturbing for the affected individuals and
those of their family members who are at risk of HD, while
dementia and personality change were most disturbing for
spouses of HD individuals (Stern and Eldridge 1975). The
differences between HD patients, family members and
medical professionals’ perception of communication defi-
cits were described by Hartelius et al. (2010). The authors
pointed out that the triangular perspective approach pro-
vides a complete picture of the difficulties caused by the
symptom and helps to provide adequate therapeutic
solutions.
Table 1 Demographic and clinical characteristics of the study group
Mean (min.–max.) SD
Age (years) 47.7 (23–76) 13.3
Education (years) 12.4 (7–19) 3.4
Age at onset of motor symptoms (years) 39.0 (21–71) 13.8
Duration of disease (years) 8.3 (0.5–28) 5.7
UHDRS Motor 41.8 (4–93) 22.2
UHDRS Cognitive 106 (0–318) 76.0
HAM-D 9.6 (0–29) 6.7
UHDRS Behavioral (total score) 16.1 (0–55) 11.1
UHDRS Apathy subscore 3.6 (0–8) 2.4
UHDRS Psychotic symptoms subscore 0.14 (0–6) 0.78
UHDRS Anxiety subscore 2.0 (0–8) 2.3
UHDRS Irritability subscore 1.9 (0–4) 1.6
UHDRS Aggression subscore 1.6 (0–7) 2.2
HAM-D, Hamilton Depression Rating Scale, UHDRS Unified Hun-
tington Disease Rating Scale
Table 2 Results of the simple regression analysis
FAS SF-36 CBI
R R2 R R2 R R2
UHDRS Motor -0.82* 0.66 -0.38* 0.13 0.58* 0.32
UHDRS Cognitive 0.76* 0.57 0.46* 0.20 -0.35 0.11
HAM-D -0.43* 0.18 -0.71* 0.49 0.47* 0.21
UHDRS
Behavioral (total
score)
-0.35* 0.11 -0.58* 0.33 0.34 0.10
UHDRS Apathy
subscore
-0.47* 0.21 -0.48* 0.22 0.30 0.07
UHDRS Psychotic
symptoms
subscore
-0.25 0.05 -0.05 0.01 -0.08 0.01
UHDRS Anxiety
subscore
-0.20 0.02 -0.23 0.04 0.19 0.02
UHDRS
Irritability
subscore
0.02 0.01 -0.24 0.04 0.14 0.01
UHDRS
Aggression
subscore
-0.19 0.02 -0.28 0.06 0.21 0.03
FAS – – 0.46* 0.20 -0.56* 0.30
Disease duration -0.54* 0.28 -0.18 0.02 0.11 0.01
Number of CAG
repeats
-0.24 0.04 0.06 0.01 0.18 0.01
Age -0.21 0.03 -0.24 0.05 0.01 0.01
Gender 0.13 0.01 -0.02 0.01 0.02 0.02
Age at onset 0.01 0.01 -0.18 0.02 -0.07 0.01
Years of education 0.01 0.01 -0.06 0.01 0.21 0.03
Coefficients of correlation (R) and coefficients of determination (R2)
of each of the predictors were calculated separately for FAS, SF-36
and CBI. Statistically significant values are marked with asterisk
HAM-D, Hamilton Depression Rating Scale, UHDRS Unified Hun-
tington Disease Rating Scale, FAS Functional Assessment Score, CBI
Caregiver Burden Inventory
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The results of the present study are consistent with the
previous studies which indicate cognitive impairment,
motor disturbances and apathy as significant factors influ-
encing activities of daily living (Hamilton et al. 2003).
Disability was also previously associated with the disease
duration (Marder et al. 2000).
Huntington’s disease QoL was reported to be related
mostly to depression (Ready et al. 2008; Ho et al. 2009),
functional capacity (Ready et al. 2008; Ho et al. 2009) and
cognitive disturbances (Ready et al. 2008). Some rela-
tionship between QoL and apathy as well as irritability was
also demonstrated (Ready et al. 2008). The profile of QoL
predictors in HD seems to be somewhat different as com-
pared to other neurodegenerative disorders. Depressive
symptoms, insomnia and disability were the predictors of
low QoL in Parkinson’s disease patients (Karlsen et al.
2000). Interestingly motor signs seem to be less important
predictors of QoL in PD (Karlsen et al. 1998, 2000) as well
as in our group of HD patients, as motor disturbances were
not an independent predictor of QoL.
The caregiver’s burden assessment results in HD have
never been reported so far. The influence of disease on the
caregivers’ well-being was measured previously using QoL
of the caregivers. The analysis of factors which constitute
caregivers’ QoL showed that the area of social relation-
ships is significantly more affected in HD as compared to
other chronic neurological disorders (McCabe et al. 2009).
This may be due to behavioral disturbances which cause
social embarrassment of the caregiver and rejection by
family members or friends. In another study, caregivers’
QoL was found to be related to functional disability and
cognitive disturbances (Ready et al. 2008). Quality of life
of the caregivers seems, however, to be a different measure
of the disease’s influence on the caregivers than the care-
givers’ burden. Physical and emotional strains affect both
measures; while in case of patient’s relatives, the former is
also influenced by psychological distress caused by fear of
being at risk of HD (Hayden et al. 1980). Aubeeluck and
Buchanan (2007) pointed out that there may be differences
in the emotional burden between those caregivers who are
and those who are not spouses of HD individuals. Care-
givers who are the spouses of HD patients may experience
the feeling of guilt due to being involved in transmission of
the disease to their children. They are additionally strained
by the responsibility to inform children about their risk of
having HD (Hayden et al. 1980). One may speculate that
those psychological factors may play a dominant role in the
caregivers’ burden since most of the burden’s variance
(61%) was not determined by the predictors related to the
patients’ symptoms according to our study. Cognitive dis-
turbances in our patients seem to have a minor influence on
the caregivers. In contrast, in Parkinson’s (D’Amelio et al.
2009) or Alzheimer’s disease (Razani et al. 2007), cogni-
tive impairment is the key predictor of caregivers’ burden.
This is, to our knowledge, the first study addressing
predictors of the patient’s functional disability, QoL and
the caregiver burden. However, it also has some limita-
tions. First, the UHDRS Cognitive score is a composite
score based on tasks with time constraints, which cannot be
treated as a marker of severity of dementia and is to a large
extent biased by motor dysfunction even at the preclinical
stage (Blekher et al. 2009). Presumably, other aspects of
cognitive dysfunction, such as executive dysfunction and
memory impairment could be more important from the
caregiver’s perspective. Second, due to the large number of
the examined factors that also influence each other, the
number of patients studied appears to be relatively small.
Finally, the relationship of the caregiver to the patient was
not analyzed. Supposedly, the perception of the patient by
the caregiver may be biased by his/her own genetic status
in case of the patient’s offspring.
Since HD patients experience physical as well as psy-
chological constraints, a multidisciplinary and coordinated
care should be provided to the patient and his/her caregiver
Table 3 Results of the multiple
regression analysis, separately
for FAS, SF-36 and CBI
b beta coefficient, CI confidence
interval, HAM-D Hamilton
Depression Rating Scale,
UHDRS Unified Huntington
Disease Rating Scale, FAS
Functional Assessment Score,
CBI Caregiver Burden
Inventory
b 95% CI p
FAS
UHDRS Motor -0.55 -0.73 to -0.37 \0.001
UHDRS Cognitive 0.21 0.02 to 0.40 0.031
UHDRS Apathy subscore -0.15 -0.28 to -0.01 0.031
Disease duration -0.16 -0.30 to -0.03 0.018
SF-36
HAM-D -0.63 -0.80 to -0.45 \0.001
UHDRS Cognitive 0.25 0.08 to 0.43 0.004
CBI
UHDRS Motor 0.45 0.24 to 0.67 \0.001
HAM-D 0.33 0.12 to 0.55 0.003
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(Veenhuizen and Tibben 2009). Patient’s disability and
QoL as well as caregivers’ burden should be taken into
consideration while planning treatment strategy. The
results of the present study show that the determinants of
those treatment targets are different.
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